LDXHF vs JNJ: Which Stock is Better?

Side-by-side comparison of Lumos Diagnostics Holdings Limited and Johnson & Johnson in 2026

Comparison Updated:

LDXHF

Lumos Diagnostics Holdings Limited

JNJ

Johnson & Johnson

$232.77

Key Metrics Comparison

MetricLDXHFJNJWinner
Market Cap$26.50M$375.37BJNJ
P/E RatioN/A17.35JNJ
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze LDXHF

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LDXHF or JNJ a better investment?

Comparing LDXHF and JNJ: Lumos Diagnostics Holdings Limited has a market cap of $26.50M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LDXHF and JNJ?

LDXHF (Lumos Diagnostics Holdings Limited) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LDXHF or JNJ?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: LDXHF or JNJ?

Both LDXHF and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: LDXHF or JNJ?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: LDXHF or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $26.50M for LDXHF.

Should I buy LDXHF or JNJ in 2026?

Both LDXHF and JNJ have investment merit. LDXHF trades at $N/A while JNJ trades at $232.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LDXHF and JNJ stock?

Key differences: Market Cap ($26.50M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy LDXHF or JNJ in 2026?

The choice between LDXHF and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between LDXHF and JNJ?

LDXHF (Lumos Diagnostics Holdings Limited) has a market cap of $26.50M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.

Popular Stock Comparisons